By Amanda Bronstad | December 8, 2022
U.S. District Judge Robin Rosenberg ruled that plaintiffs' experts in the Zantac multidistrict litigation had "unreliable methodologies" and "analytical leaps" from existing data.
By Scott Graham | November 22, 2022
Debevoise & Plimpton partner David Bernstein says the time is right for the Supreme Court to assess the Second Circuit's Rogers v. Grimaldi test, and decide if it strikes the right balance.
By Habiba Cullen-Jafar | November 17, 2022
Estee Lauder is adding another beauty name to its belt with the acquisition of the Tom Ford brand.
By Amanda Bronstad | November 2, 2022
The agreements in principle, announced on Wednesday, are dependent on the participation of cities, counties and states suing the pharmacies over the opioid crisis.
By Allison Dunn | October 19, 2022
"[The] plaintiffs' only purported basis for economic injury stems from their allegation that the Baby Food Products posed a threat of future harm...," Judge Michael S. Nachmanoff wrote, dismissing the case.
By Cheryl Miller | September 14, 2022
California's lawsuit is similar to one filed last year by District of Columbia Attorney General Karl Racine. Racine is appealing a judge's ruling earlier this year dismissing the complaint.
By Brian Lee | August 30, 2022
A cashier's personal beliefs can not restrict access to products including birth control, condoms, emergency contraceptives, and other medications, New York Attorney General Letitia James said.
By Alaina Lancaster | August 10, 2022
The bench ruling from U.S. District Judge Charles Breyer marks the first bench trial to find Walgreens liable for public nuisance claims in the nationwide multidistrict litigation stemming from the ongoing opioid epidemic, according to San Francisco City Attorney David Chiu.
By Scott Graham | May 19, 2022
The "Rogers v. Grimaldi" test for balancing artistic expression against trademark protection applies, even in the world of NFTs. But that wasn't enough to stop Hermes' suit against Mason Rothschild from proceeding.
By Amanda Bronstad | May 5, 2022
Another opioid trial began on April 25 in San Francisco against Walgreens, as well as manufacturers Allergan and Teva, and Teva's distribution subsidiary Anda.
Presented by BigVoodoo
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
The National Law Journal honors attorneys & judges who've made a remarkable difference in the legal profession in the D.C. area.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
Job Opportunity: Location: Prestigious Florida Law Firm seeks to hire a Business attorney with at least 5 years of experience for their Ft. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS